A 30-year-old female patient.
Complaints: For 2 months, the patient had chronic dry cough, weight loss, and loss of appetite.
Chest X-ray showed a fluffy shadowing in the right upper lobe. However, sputum for AFB was negative. The clinical diagnosis of pulmonary tuberculosis was made, and a standard regimen of medication including rifampicin was prescribed.
The patient came to us on the second day, hoping that resonant therapy with an antibacterial emitter might help alongside medications.
Treatment started using GI and RC emitters. Due to high EAF readings on the liver, the RC emitter was also applied to the liver. Treatment was conducted every other day as the patient felt very tired after each session.
An interesting phenomenon was observed: on treatment days, urine was clear and colorless, on days without treatment, urine was reddish. This phenomenon was observed over 7 days, where on 3 treatment days, the urine was clear, and on 4 non-treatment days, it was reddish, although the patient took the same dose of rifampicin. She was concerned that the IR radiation on the liver might reduce the effectiveness of the medication, as this method is not proven. We gave her the choice to continue treatment but without the liver emitter or to stop the course. She chose to proceed with only medication therapy.
Side Effects: The primary symptom on IR therapy days was drowsiness.
Comments: The observed phenomenon might be related to the significant influence on the liver's processing of medications in general or specifically rifampicin in this case or paracetamol in the previously described case.
Complaints: For 2 months, the patient had chronic dry cough, weight loss, and loss of appetite.
Chest X-ray showed a fluffy shadowing in the right upper lobe. However, sputum for AFB was negative. The clinical diagnosis of pulmonary tuberculosis was made, and a standard regimen of medication including rifampicin was prescribed.
The patient came to us on the second day, hoping that resonant therapy with an antibacterial emitter might help alongside medications.
Treatment started using GI and RC emitters. Due to high EAF readings on the liver, the RC emitter was also applied to the liver. Treatment was conducted every other day as the patient felt very tired after each session.
An interesting phenomenon was observed: on treatment days, urine was clear and colorless, on days without treatment, urine was reddish. This phenomenon was observed over 7 days, where on 3 treatment days, the urine was clear, and on 4 non-treatment days, it was reddish, although the patient took the same dose of rifampicin. She was concerned that the IR radiation on the liver might reduce the effectiveness of the medication, as this method is not proven. We gave her the choice to continue treatment but without the liver emitter or to stop the course. She chose to proceed with only medication therapy.
Side Effects: The primary symptom on IR therapy days was drowsiness.
Comments: The observed phenomenon might be related to the significant influence on the liver's processing of medications in general or specifically rifampicin in this case or paracetamol in the previously described case.